MDT

84.32

-4.25%↓

VEEV

213.88

-3.93%↓

A

104.85

-5.86%↓

HQY

77.88

-7.52%↓

PDCO

31.07

-0.61%↓

MDT

84.32

-4.25%↓

VEEV

213.88

-3.93%↓

A

104.85

-5.86%↓

HQY

77.88

-7.52%↓

PDCO

31.07

-0.61%↓

MDT

84.32

-4.25%↓

VEEV

213.88

-3.93%↓

A

104.85

-5.86%↓

HQY

77.88

-7.52%↓

PDCO

31.07

-0.61%↓

MDT

84.32

-4.25%↓

VEEV

213.88

-3.93%↓

A

104.85

-5.86%↓

HQY

77.88

-7.52%↓

PDCO

31.07

-0.61%↓

MDT

84.32

-4.25%↓

VEEV

213.88

-3.93%↓

A

104.85

-5.86%↓

HQY

77.88

-7.52%↓

PDCO

31.07

-0.61%↓

Search

Bausch Health Cos Inc

Deschisă

SectorSănătate

5.24 -9.81

Rezumat

Modificarea prețului

24h

Curent

Minim

5.09

Maxim

5.8

Indicatori cheie

By Trading Economics

Venit

190M

98M

Vânzări

49M

2.6B

EPS

1.16

Marjă de profit

3.83

Angajați

20,700

EBITDA

206M

853M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+52.91% upside

Dividende

By Dow Jones

Următoarele câștiguri

30 apr. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

50M

2.4B

Deschiderea anterioară

15.05

Închiderea anterioară

5.24

Sentimentul știrilor

By Acuity

42%

58%

137 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Bausch Health Cos Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 oct. 2024, 23:57 UTC

Acțiuni populare

Stocks to Watch: Netflix, MGP Ingredients, Bausch Health

Comparație

Modificare preț

Bausch Health Cos Inc Așteptări

Obiectiv de preț

By TipRanks

52.91% sus

Prognoză pe 12 luni

Medie 8.67 USD  52.91%

Maxim 12 USD

Minim 7 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruBausch Health Cos Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

6 ratings

0

Cumpărare

5

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

N/A / 6.2366Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

137 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.